Elevating the Patient Voice in Metastatic Hormone-Sensitive Prostate Cancer Clinical Trials

被引:2
|
作者
Dzimitrowicz, Hannah E. [1 ]
Armstrong, Andrew J. [1 ]
机构
[1] Duke Univ, Dept Med, Duke Canc Inst Ctr Prostate & Urol Canc, Durham, NC 27708 USA
关键词
ANDROGEN DEPRIVATION THERAPY; QUALITY-OF-LIFE; ABIRATERONE;
D O I
10.1200/JCO.21.02504
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:807 / +
页数:5
相关论文
共 50 条
  • [1] Metastatic Hormone-sensitive Prostate Cancer: Patient Selection for Prostate Radiotherapy
    Chakrabarti, Deep
    Parker, Chris C.
    EUROPEAN UROLOGY, 2024, 86 (01) : 18 - 19
  • [2] It Is Time to Harmonize the Design and Conduct of Clinical Trials in Metastatic Hormone-sensitive Prostate Cancer
    Sridhar, Srikala S.
    Sweeney, Christopher J.
    EUROPEAN UROLOGY, 2016, 70 (02) : 263 - 264
  • [3] Metastatic hormone-sensitive prostate cancer
    Gravis, Gwenaelle
    Salem, Naji
    Walz, Jochen
    BULLETIN DU CANCER, 2015, 102 (01) : 57 - 64
  • [5] Rezvilutamide for metastatic hormone-sensitive prostate cancer
    Ye, Dingwei
    Gu, Weijie
    Li, Junliang
    LANCET ONCOLOGY, 2022, 23 (11): : E491 - E491
  • [6] Treatment of metastatic hormone-sensitive prostate cancer
    Rane, Jayant K.
    Chowdhury, Amani
    Kinnaird, William
    Marks, Gillian
    Davda, Reena
    TRENDS IN UROLOGY & MENS HEALTH, 2021, 12 (06) : 7 - 10
  • [7] Management of Metastatic Hormone-Sensitive Prostate Cancer
    Bernard, Brandon
    Sweeney, Christopher J.
    CURRENT UROLOGY REPORTS, 2015, 16 (03)
  • [8] Docetaxel for hormone-sensitive metastatic prostate cancer
    Baker, Holly
    LANCET ONCOLOGY, 2015, 16 (09): : E432 - E432
  • [9] Management of Metastatic Hormone-Sensitive Prostate Cancer
    Brandon Bernard
    Christopher J. Sweeney
    Current Urology Reports, 2015, 16
  • [10] Management of Hormone-Sensitive Metastatic Prostate Cancer
    Agarwal, Neeraj
    Hussain, Maha
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 27 (06) : 1221 - +